The Centre has proposed integrating Good Storage and Distribution Practices into existing drug rules to enhance quality checks across the pharmaceutical supply chain. This initiative aims to address risks like contamination, improper storage, and unauthorized distribution from manufacturing units to patients. The Union health ministry invited objections and suggestions on the proposed framework, which covers procurement, storage, transportation, and documentation. Developed by drug authorities, the guidelines are expected to strengthen inspections and ensure pharmaceutical safety throughout the distribution network.
This page is a shareable card. Download our app to get the full swipe experience!